PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates.\', \'Department of Basic Science, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.\', \'Immunology Research Lab, Department of Pediatrics, College of Medicine, King Saud University, Saudi Arabia; Department of Pediatrics, College of Medicine, King Saud University, Saudi Arabia.\', \'Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.\', \'Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Prince Abdullah Ben Khaled Celiac Disease Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Saudi Arabia. Electronic address: rhalwani@sharjah.ac.ae.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0014-2999(21)00527-610.1016/j.ejphar.2021.174374
?:doi
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34303662
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all